SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3g7x'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_A_HSMA176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	7 / 9	SER A 20 TYR A 29 PHE A 98 TYR A 100 ASP A 120 ILE A 122 TRP A 137	None None None HSM A 174 (-3.6A) None None None	0.55A	1qftA-3g7xA: 35.0	1qftA-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_A_HSMA176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	7 / 9	TYR A 29 VAL A 51 PHE A 98 TYR A 100 ASP A 120 ILE A 122 TRP A 137	None None None HSM A 174 (-3.6A) None None None	0.22A	1qftA-3g7xA: 35.0	1qftA-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_A_HSMA177_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	10 / 10	TYR A 36 ASP A 39 VAL A 41 TRP A 42 GLU A 82 TYR A 100 PHE A 108 ASP A 110 VAL A 124 GLU A 135	None HSM A 174 (-2.8A) HSM A 174 ( 4.3A) HSM A 174 (-3.7A) HSM A 174 (-2.8A) HSM A 174 (-3.6A) HSM A 174 (-4.0A) HSM A 174 (-3.2A) HSM A 174 (-4.4A) HSM A 174 (-3.4A)	0.18A	1qftA-3g7xA: 35.0	1qftA-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_B_HSMB176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	7 / 9	SER A 20 TYR A 29 PHE A 98 TYR A 100 ASP A 120 ILE A 122 TRP A 137	None None None HSM A 174 (-3.6A) None None None	0.54A	1qftB-3g7xA: 33.4	1qftB-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_B_HSMB176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	7 / 9	TYR A 29 VAL A 51 PHE A 98 TYR A 100 ASP A 120 ILE A 122 TRP A 137	None None None HSM A 174 (-3.6A) None None None	0.24A	1qftB-3g7xA: 33.4	1qftB-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFT_B_HSMB177_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	10 / 10	TYR A 36 ASP A 39 VAL A 41 TRP A 42 GLU A 82 TYR A 100 PHE A 108 ASP A 110 VAL A 124 GLU A 135	None HSM A 174 (-2.8A) HSM A 174 ( 4.3A) HSM A 174 (-3.7A) HSM A 174 (-2.8A) HSM A 174 (-3.6A) HSM A 174 (-4.0A) HSM A 174 (-3.2A) HSM A 174 (-4.4A) HSM A 174 (-3.4A)	0.19A	1qftB-3g7xA: 33.4	1qftB-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFV_A_HSMA176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	10 / 10	TYR A 36 ASP A 39 VAL A 41 TRP A 42 GLU A 82 TYR A 100 PHE A 108 ASP A 110 VAL A 124 GLU A 135	None HSM A 174 (-2.8A) HSM A 174 ( 4.3A) HSM A 174 (-3.7A) HSM A 174 (-2.8A) HSM A 174 (-3.6A) HSM A 174 (-4.0A) HSM A 174 (-3.2A) HSM A 174 (-4.4A) HSM A 174 (-3.4A)	0.14A	1qfvA-3g7xA: 35.1	1qfvA-3g7xA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QFV_B_HSMB176_1 (PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2))	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	10 / 10	TYR A 36 ASP A 39 VAL A 41 TRP A 42 GLU A 82 TYR A 100 PHE A 108 ASP A 110 VAL A 124 GLU A 135	None HSM A 174 (-2.8A) HSM A 174 ( 4.3A) HSM A 174 (-3.7A) HSM A 174 (-2.8A) HSM A 174 (-3.6A) HSM A 174 (-4.0A) HSM A 174 (-3.2A) HSM A 174 (-4.4A) HSM A 174 (-3.4A)	0.21A	1qfvB-3g7xA: 33.3	1qfvB-3g7xA: 99.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_A_HSMA1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 6	SER A 20 TYR A 29 ASP A 120 TRP A 137	None	0.83A	2x45A-3g7xA: 17.9	2x45A-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_A_HSMA1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 6	TYR A 29 VAL A 51 ASP A 120 TRP A 137	None	0.52A	2x45A-3g7xA: 17.9	2x45A-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_B_HSMB1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	SER A 20 TYR A 29 ASP A 120 TRP A 137	None	0.81A	2x45B-3g7xA: 18.0	2x45B-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_B_HSMB1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	TYR A 29 VAL A 51 ASP A 120 TRP A 137	None	0.52A	2x45B-3g7xA: 18.0	2x45B-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_C_HSMC1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	SER A 20 TYR A 29 ASP A 120 TRP A 137	None	0.80A	2x45C-3g7xA: 18.0	2x45C-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_C_HSMC1160_1 (ALLERGEN ARG R 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	TYR A 29 VAL A 51 ASP A 120 TRP A 137	None	0.50A	2x45C-3g7xA: 18.0	2x45C-3g7xA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZBU_B_ADNB502_1 (UNCHARACTERIZED CONSERVED PROTEIN)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 5	TRP A 137 PHE A 152 TYR A 134 VAL A 124	None None None HSM A 174 (-4.4A)	1.33A	2zbuB-3g7xA: 0.4	2zbuB-3g7xA: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BU1_A_HSMA301_1 (LIPOCALIN)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	SER A 20 TYR A 29 ASP A 120 TRP A 137	None	0.70A	3bu1A-3g7xA: 17.3	3bu1A-3g7xA: 26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BU1_A_HSMA301_1 (LIPOCALIN)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	TYR A 29 VAL A 51 ASP A 120 TRP A 137	None	0.55A	3bu1A-3g7xA: 17.3	3bu1A-3g7xA: 26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EJ8_C_H4BC3902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	MET A 31 ILE A 144 TRP A 137 PHE A 152	None	1.35A	3ej8C-3g7xA: 0.0 3ej8D-3g7xA: 0.0	3ej8C-3g7xA: 16.59 3ej8D-3g7xA: 16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K0B_B_SAMB504_1 (S-ADENOSYLMETHIONINE SYNTHASE)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 8	LYS A 19 ALA A 23 TYR A 29 ASP A 116	None	1.01A	4k0bB-3g7xA: undetectable	4k0bB-3g7xA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L7I_B_SAMB501_1 (S-ADENOSYLMETHIONINE SYNTHASE)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 8	LYS A 19 ALA A 23 TYR A 29 ASP A 116	None	1.00A	4l7iB-3g7xA: undetectable	4l7iB-3g7xA: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YV5_A_SVRA205_1 (BASIC PHOSPHOLIPASE A2 HOMOLOG 2)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	ASN A 27 TYR A 141 LEU A 136 PHE A 152	None	1.01A	4yv5A-3g7xA: undetectable	4yv5A-3g7xA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YV5_B_SVRB207_2 (BASIC PHOSPHOLIPASE A2 HOMOLOG 2)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 7	ASN A 27 TYR A 141 LEU A 136 PHE A 152	None	1.09A	4yv5B-3g7xA: undetectable	4yv5B-3g7xA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HW8_H_FK5H201_1 (FK506-BINDING PROTEIN 1)	3g7x	FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2 (Rhipicephalus appendiculatus)	4 / 8	ASP A 39 PHE A 67 ILE A 122 TRP A 137	HSM A 174 (-2.8A) None None None	0.99A	5hw8H-3g7xA: undetectable	5hw8H-3g7xA: 19.21

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1QFT_A_HSMA176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",7,"SER A  20;TYR A  29;PHE A  98;TYR A 100;ASP A 120;ILE A 122;TRP A 137","None;None;None;HSM A 174 (-3.6A);None;None;None","0.55A","1qftA-3g7xA:35.0","1qftA-3g7xA:99.42"],["1QFT_A_HSMA176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",7,"TYR A  29;VAL A  51;PHE A  98;TYR A 100;ASP A 120;ILE A 122;TRP A 137","None;None;None;HSM A 174 (-3.6A);None;None;None","0.22A","1qftA-3g7xA:35.0","1qftA-3g7xA:99.42"],["1QFT_A_HSMA177_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",10,"TYR A  36;ASP A  39;VAL A  41;TRP A  42;GLU A  82;TYR A 100;PHE A 108;ASP A 110;VAL A 124;GLU A 135","None;HSM A 174 (-2.8A);HSM A 174 ( 4.3A);HSM A 174 (-3.7A);HSM A 174 (-2.8A);HSM A 174 (-3.6A);HSM A 174 (-4.0A);HSM A 174 (-3.2A);HSM A 174 (-4.4A);HSM A 174 (-3.4A)","0.18A","1qftA-3g7xA:35.0","1qftA-3g7xA:99.42"],["1QFT_B_HSMB176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",7,"SER A  20;TYR A  29;PHE A  98;TYR A 100;ASP A 120;ILE A 122;TRP A 137","None;None;None;HSM A 174 (-3.6A);None;None;None","0.54A","1qftB-3g7xA:33.4","1qftB-3g7xA:99.42"],["1QFT_B_HSMB176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",7,"TYR A  29;VAL A  51;PHE A  98;TYR A 100;ASP A 120;ILE A 122;TRP A 137","None;None;None;HSM A 174 (-3.6A);None;None;None","0.24A","1qftB-3g7xA:33.4","1qftB-3g7xA:99.42"],["1QFT_B_HSMB177_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",10,"TYR A  36;ASP A  39;VAL A  41;TRP A  42;GLU A  82;TYR A 100;PHE A 108;ASP A 110;VAL A 124;GLU A 135","None;HSM A 174 (-2.8A);HSM A 174 ( 4.3A);HSM A 174 (-3.7A);HSM A 174 (-2.8A);HSM A 174 (-3.6A);HSM A 174 (-4.0A);HSM A 174 (-3.2A);HSM A 174 (-4.4A);HSM A 174 (-3.4A)","0.19A","1qftB-3g7xA:33.4","1qftB-3g7xA:99.42"],["1QFV_A_HSMA176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",10,"TYR A  36;ASP A  39;VAL A  41;TRP A  42;GLU A  82;TYR A 100;PHE A 108;ASP A 110;VAL A 124;GLU A 135","None;HSM A 174 (-2.8A);HSM A 174 ( 4.3A);HSM A 174 (-3.7A);HSM A 174 (-2.8A);HSM A 174 (-3.6A);HSM A 174 (-4.0A);HSM A 174 (-3.2A);HSM A 174 (-4.4A);HSM A 174 (-3.4A)","0.14A","1qfvA-3g7xA:35.1","1qfvA-3g7xA:99.42"],["1QFV_B_HSMB176_1","PROTEIN (FEMALE-SPECIFIC HISTAMINE BINDING PROTEIN 2)","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",10,"TYR A  36;ASP A  39;VAL A  41;TRP A  42;GLU A  82;TYR A 100;PHE A 108;ASP A 110;VAL A 124;GLU A 135","None;HSM A 174 (-2.8A);HSM A 174 ( 4.3A);HSM A 174 (-3.7A);HSM A 174 (-2.8A);HSM A 174 (-3.6A);HSM A 174 (-4.0A);HSM A 174 (-3.2A);HSM A 174 (-4.4A);HSM A 174 (-3.4A)","0.21A","1qfvB-3g7xA:33.3","1qfvB-3g7xA:99.42"],["2X45_A_HSMA1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"SER A  20;TYR A  29;ASP A 120;TRP A 137","None","0.83A","2x45A-3g7xA:17.9","2x45A-3g7xA:24.59"],["2X45_A_HSMA1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"TYR A  29;VAL A  51;ASP A 120;TRP A 137","None","0.52A","2x45A-3g7xA:17.9","2x45A-3g7xA:24.59"],["2X45_B_HSMB1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"SER A  20;TYR A  29;ASP A 120;TRP A 137","None","0.81A","2x45B-3g7xA:18.0","2x45B-3g7xA:24.59"],["2X45_B_HSMB1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"TYR A  29;VAL A  51;ASP A 120;TRP A 137","None","0.52A","2x45B-3g7xA:18.0","2x45B-3g7xA:24.59"],["2X45_C_HSMC1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"SER A  20;TYR A  29;ASP A 120;TRP A 137","None","0.80A","2x45C-3g7xA:18.0","2x45C-3g7xA:24.59"],["2X45_C_HSMC1160_1","ALLERGEN ARG R 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"TYR A  29;VAL A  51;ASP A 120;TRP A 137","None","0.50A","2x45C-3g7xA:18.0","2x45C-3g7xA:24.59"],["2ZBU_B_ADNB502_1","UNCHARACTERIZED CONSERVED PROTEIN","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"TRP A 137;PHE A 152;TYR A 134;VAL A 124","None;None;None;HSM A 174 (-4.4A)","1.33A","2zbuB-3g7xA:0.4","2zbuB-3g7xA:22.36"],["3BU1_A_HSMA301_1","LIPOCALIN","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"SER A  20;TYR A  29;ASP A 120;TRP A 137","None","0.70A","3bu1A-3g7xA:17.3","3bu1A-3g7xA:26.67"],["3BU1_A_HSMA301_1","LIPOCALIN","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"TYR A  29;VAL A  51;ASP A 120;TRP A 137","None","0.55A","3bu1A-3g7xA:17.3","3bu1A-3g7xA:26.67"],["3EJ8_C_H4BC3902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"MET A  31;ILE A 144;TRP A 137;PHE A 152","None","1.35A","3ej8C-3g7xA:0.0;3ej8D-3g7xA:0.0","3ej8C-3g7xA:16.59;3ej8D-3g7xA:16.59"],["4K0B_B_SAMB504_1","S-ADENOSYLMETHIONINE SYNTHASE","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"LYS A  19;ALA A  23;TYR A  29;ASP A 116","None","1.01A","4k0bB-3g7xA:undetectable","4k0bB-3g7xA:19.40"],["4L7I_B_SAMB501_1","S-ADENOSYLMETHIONINE SYNTHASE","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"LYS A  19;ALA A  23;TYR A  29;ASP A 116","None","1.00A","4l7iB-3g7xA:undetectable","4l7iB-3g7xA:19.40"],["4YV5_A_SVRA205_1","BASIC PHOSPHOLIPASE A2 HOMOLOG 2","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"ASN A  27;TYR A 141;LEU A 136;PHE A 152","None","1.01A","4yv5A-3g7xA:undetectable","4yv5A-3g7xA:19.10"],["4YV5_B_SVRB207_2","BASIC PHOSPHOLIPASE A2 HOMOLOG 2","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"ASN A  27;TYR A 141;LEU A 136;PHE A 152","None","1.09A","4yv5B-3g7xA:undetectable","4yv5B-3g7xA:19.10"],["5HW8_H_FK5H201_1","FK506-BINDING PROTEIN 1","3g7x","FEMALE-SPECIFIC HISTAMINE-BINDING PROTEIN 2","Rhipicephalus appendiculatus",4,"ASP A  39;PHE A  67;ILE A 122;TRP A 137","HSM A 174 (-2.8A);None;None;None","0.99A","5hw8H-3g7xA:undetectable","5hw8H-3g7xA:19.21"]]